Light Mode
$0.0001 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0001, and at the day’s high of $0.0001
+0.00 (+0.00%) / 6M
Momentum, market sentiment, and recent alerts
KLDO reads not so good: the 12-month move is +0.0%.
No alerts for KLDO in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Kaleido Biosciences, Inc. is a clinical-stage healthcare company, which engages in the provision of healthcare services. It focuses on leveraging the microbiome organ to treat disease and improve human health. The firm offers microbiome metabolic therapies (MMT), which are designed to modulate the metabolic output and profile of the microbiome by driving the function and composition of the organ's existing microbes. The company was founded by Geoffrey von Maltzahn and Noubar B. Afeyan on January 27, 2015 and is headquartered in Lexington, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.